According to a report from Vaping Post on November 6, the French Ministry of Health's website, Santé.fr, once issued a statement claiming that "e-cigarettes help with smoking cessation and the theory that they serve as a gateway to smoking does not exist. The harm of e-cigarettes is lower than that of traditional cigarettes." This statement has sparked widespread discussion.
Established in 2016, this platform is part of the modernization of the French healthcare system laws, aiming to provide the public with reliable and transparent health information. The website reports directly to the French Ministry of Health and Public Health, and collaborates with regional health agencies (ARS) and public health organizations.
According to reports, a few days ago, the website published a new article titled "Are e-cigarettes dangerous?". As is customary, whenever the French government releases information about e-cigarettes, it always attracts widespread public attention. This time, Santé.fr cited a study by Cochrane, mentioning the significant effectiveness of e-cigarettes in smoking cessation. The website also referenced a recent Swiss study, pointing out that e-cigarettes are more effective in smoking cessation than other nicotine replacement therapies, and even better than psychological support.
The website also explicitly states, "Contrary to previous concerns, e-cigarettes have not become a gateway to smoking." The website also provides an assessment of the long-term health effects of e-cigarettes, stating that "Twenty-year data shows that the medium to long-term toxicity of e-cigarettes is reassuring.
However, shortly after this page was published, it disappeared from the website. This sudden change has raised public doubts: Was the page published without authorization? Was it under pressure from anti e-cigarette organizations? Does it involve the interests of large tobacco companies?
These issues have sparked widespread discussion within the e-cigarette industry.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
